Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir Plus Ribavirin in Treatment-Naïve Chronic HCV Genotype 1 or 3
NCT02074514Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir in hepatitis C (HCV), sponsored by Gilead Sciences. Started Mar 2014; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02074514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074514.